Does Mounjaro Make You Lose Muscle Mass?

What SURMOUNT-1 actually found about body composition

The SURMOUNT-1 trial, published in the New England Journal of Medicine, randomised 2,539 adults with obesity over 72 weeks and recorded some of the largest average body-weight reductions seen in a pharmaceutical trial at the time, around 20–21% at the highest dose. What those headline figures don't immediately show is the composition of the weight that was lost.

Body composition measurements within the SURMOUNT programme consistently showed that the majority of weight lost was adipose (fat) tissue. That is genuinely encouraging. At the same time, lean mass (which includes muscle, bone and organ tissue) did fall in absolute terms. This is not unique to tirzepatide; it happens with any sustained calorie deficit, whether from dietary restriction alone or from medication. The relevant question isn't whether lean mass falls at all, but by how much relative to fat, and what can be done to limit it.

A useful framing: someone losing 20kg of total weight might lose roughly 15–16kg of fat and 4–5kg of lean tissue. The exact ratio shifts depending on how active they are and how much protein they eat throughout treatment. more detail on the composition of weight lost on Mounjaro covers how those ratios are tracked clinically.

Why the muscle-loss concern matters more than it might seem at first

There is a common assumption that if the scales are moving in the right direction, the job is done. Muscle loss complicates that picture in a few ways. Muscle tissue is metabolically active, it contributes to resting energy expenditure, which means losing a meaningful amount can make it harder to maintain weight loss over the long term once treatment ends or is paused.

Muscle also matters for functional strength, balance and bone density, particularly in older adults. For people in their fifties or sixties using tirzepatide, preserving lean mass isn't just a cosmetic consideration; it has real implications for how they feel and move day to day. This is one reason our clinical team takes a whole-picture view of your health before and during treatment, rather than tracking weight as the single measure of progress.

Many patients ask whether Mounjaro causes muscle loss at a worse rate than other weight-loss approaches, and current evidence doesn't suggest it does. The proportion of lean mass lost on GLP-1 and dual-agonist treatment appears broadly similar to what occurs during equivalent calorie restriction without medication, though research specifically comparing body-composition outcomes across these approaches is still developing.

What actually protects muscle during Mounjaro treatment

Two factors consistently appear in the evidence base: protein intake and resistance exercise. Both are practical, and neither requires anything elaborate.

Protein matters because amino acids from dietary protein are the raw material muscle tissue uses for repair and maintenance. When someone is eating less overall (as most people do on tirzepatide, because appetite falls) total protein intake often falls too, unless it is actively maintained. Aiming to keep protein intake adequate (your prescriber or a dietitian can give you a target based on your weight and activity level) helps signal to the body that muscle tissue should be preserved rather than broken down for fuel. If you are wondering whether Mounjaro burns muscle for energy, the short answer is that it can contribute to lean tissue losses when protein intake is consistently low, which is exactly why hitting your protein target matters.

Resistance training (lifting weights, bodyweight exercises, resistance bands) provides a direct stimulus for muscle retention. Even two sessions a week has meaningful impact. You don't need to join a gym or follow a structured programme; the principle is simply that muscles under load respond by maintaining their mass. The NHS Live Well healthy weight guidance includes activity recommendations that sit alongside weight-management treatment well.

For context on how this fits into the broader picture of weight-loss treatment options, protein targets and activity guidance are usually discussed during the clinical review process, not handed out as generic advice, but shaped around the individual.

Questions worth raising with your prescriber

If you are already on Mounjaro or tirzepatide and are concerned about muscle loss, a few practical questions are worth putting to your prescriber or a registered dietitian. How much protein are you currently eating? Are you doing any resistance activity? Has your dose recently increased, which can temporarily sharpen the appetite-suppression effect and make eating enough protein harder?

Some people on treatment notice that their appetite is so reduced at certain points in their titration schedule that hitting a protein target feels difficult. This is a real and recognised challenge, not a failure on your part. Small, protein-dense meals and protein-rich snacks can help bridge the gap. People also frequently ask whether you lose muscle mass on Mounjaro when appetite suppression is at its strongest, and the honest answer is that the risk is higher if protein intake drops significantly, which is why your prescriber is the right person to work through this with you. It's a question our team hears regularly.

Separately, patients often want to know whether you lose muscle on Mounjaro in ways that affect how they feel physically, and this connects directly to the hair changes some people notice on Mounjaro, which are often linked to the same underlying mechanism (rapid weight loss affecting cellular turnover) and are separate from muscle loss but worth knowing about as part of the full picture. If you'd like to discuss your situation with a clinician, you can start a free consultation and have your questions reviewed the same day by a GPhC-registered prescriber.